These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12358845)

  • 1. Comparison of different techniques for detection of anti-HLA antibodies in sera from patients awaiting kidney transplantation.
    Uboldi de Capei M; Praticò L; Curtoni ES
    Eur J Immunogenet; 2002 Oct; 29(5):379-82. PubMed ID: 12358845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC
    Transplant Proc; 2009; 41(1):95-8. PubMed ID: 19249487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodologies for anti-HLA antibody screening in patients awaiting kidney transplant: a comparative study.
    Minucci PB; Grimaldi V; Casamassimi A; Cacciatore F; Sommese L; Picascia A; Resse M; Sabia C; Russo A; Napoli C
    Exp Clin Transplant; 2011 Dec; 9(6):381-6. PubMed ID: 22142045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of test technique on sensitization status of patients on the kidney transplant waiting list.
    Gombos P; Opelz G; Scherer S; Morath C; Zeier M; Schemmer P; Süsal C
    Am J Transplant; 2013 Aug; 13(8):2075-82. PubMed ID: 23841891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of HLA-specific antibodies by PRA-STAT and their association with transplant outcome.
    Worthington JE; Thomas AA; Dyer PA; Martin S
    Transplantation; 1998 Jan; 65(1):121-5. PubMed ID: 9448156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HLA Antibodies Testing on Solid Phase: Comparative Evaluation of Different Kit Vendors Through Luminex Technology.
    Minucci PB; Resse M; Sabia C; Esposito A; De Iorio G; Napoli C
    Exp Clin Transplant; 2017 Dec; 15(6):636-640. PubMed ID: 28585912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplantation monitoring of HLA antibodies by complement dependent cytotoxicity and Luminex-based assays.
    Katalinić N; Fućak M; Crnić T; Ćurković M; Starčević A; Balen S
    Wien Klin Wochenschr; 2017 Jan; 129(1-2):33-37. PubMed ID: 27743177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and specification of noncomplement binding anti-HLA alloantibodies.
    Arnold ML; Zacher T; Dechant M; Kalden JR; Doxiadis II; Spriewald BM
    Hum Immunol; 2004 Nov; 65(11):1288-96. PubMed ID: 15556679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of HLA class I-specific antibodies by the QuikScreen enzyme-linked immunosorbent assay.
    Lucas DP; Paparounis ML; Myers L; Hart JM; Zachary AA
    Clin Diagn Lab Immunol; 1997 May; 4(3):252-7. PubMed ID: 9144358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-HLA antibodies after bone graft and their impact on kidney transplant programs].
    Mosconi G; Baraldi O; Fantinati C; Cappuccilli ML; Corsini S; Zanelli P; Bassi A; Buscaroli B; Feliciangeli G; Stefoni S
    G Ital Nefrol; 2009; 26 Suppl 45():S58-63. PubMed ID: 19382096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison Between Phenotypic Bead Assay and Single Antigen Bead Assay for Determining Specificity of HLA Antibodies in Kidney Transplant Waiting List.
    Thammanichanond D; Sukhumvat S; Tammakorn C; Siriyotha S; Kantachuvesiri S
    Transplant Proc; 2020; 52(6):1675-1679. PubMed ID: 32448666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
    Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
    Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: Luminex technology for HLA antibody detection in organ transplantation.
    Tait BD; Hudson F; Cantwell L; Brewin G; Holdsworth R; Bennett G; Jose M
    Nephrology (Carlton); 2009 Apr; 14(2):247-54. PubMed ID: 19207861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of permissible and immunogenic HLA antigens based on epitope analysis of the HLA specific antibodies produced in sensitized patients.
    Papassavas AC; Stavropoulos-Giokas C; Boletis J; Ioannou S; Iniotaki-Theodoraki A; Kostakis A
    Eur J Immunogenet; 2002 Oct; 29(5):401-7. PubMed ID: 12358849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: the North Italy Transplant program approach.
    Poli F; Cardillo M; Scalamogna M
    Hum Immunol; 2009 Aug; 70(8):631-5. PubMed ID: 19527758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization and sensitivity: defining the unsensitized patient.
    Gebel HM; Bray RA
    Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assignment of C1q-binding HLA antibodies as unacceptable HLA antigens avoids positive CDC-crossmatches prior to transplantation of deceased donor organs.
    Juhl D; Marget M; Hallensleben M; Görg S; Ziemann M
    Transpl Immunol; 2017 Mar; 41():17-21. PubMed ID: 28088367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of panel-reactive anti-HLA class I antibodies by enzyme-linked immunosorbent assay or lymphocytotoxicity. Results of a blinded, controlled multicenter study.
    Buelow R; Mercier I; Glanville L; Regan J; Ellingson L; Janda G; Claas F; Colombe B; Gelder F; Grosse-Wilde H
    Hum Immunol; 1995 Sep; 44(1):1-11. PubMed ID: 8522449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.